# KARYOPHARM THERAPEUTICS INC COM

KARYOPHARM THERAPEUTICS INC COM is a security (CUSIP 48576U106) tracked across SEC portfolio filings. 1 institutional managers reported $468K on Form 13F as of 2026-03-31; 1 registered fund positions totaling $32K via N-PORT as of 2022-09-30.

## Summary

- Issuer: KARYOPHARM THERAPEUTICS INC
- Class: COM
- CUSIP: 48576U106
- Asset category: EC
- 13F holders: 1
- 13F value: $468K
- 13F period: 2026-03-31
- N-PORT fund positions: 1
- N-PORT value: $32K
- N-PORT report: 2022-09-30

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| Birchview Capital, LP | BURLINGTON, VT | $468K | 83,952 |

## Top fund holders (N-PORT)

| Fund | Registrant | Value | % of fund |
| --- | --- | --- | --- |
| Weiss Strategic Interval Fund | Weiss Strategic Interval Fund | $32K | 0.62% |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/48576u106.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.